CLDX icon

Celldex Therapeutics

115 hedge funds and large institutions have $710M invested in Celldex Therapeutics in 2021 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 39 increasing their positions, 38 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

5.84% less ownership

Funds ownership: 93.04%87.2% (-5.8%)

12% less funds holding

Funds holding: 130115 (-15)

45% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 33

Holders
115
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$22.4M
Puts
$16.3M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
76
$339K
77
$333K
78
$314K
79
$299K
80
$288K
81
$237K
82
$232K
83
$145K
84
$103K
85
$72K
86
$61.8K
87
$58K
88
$52K
89
$52K
90
$51K
91
$50K
92
$40K
93
$35K
94
$31.6K
95
$31K
96
$21K
97
$18K
98
$8K
99
$8K
100
$7K